Our data point towards several potential mechanisms through which hepatic Angptl4 silencing may attenuate hyperlipidaemia, and accordingly atherosclerosis development, which only partly overlap with those of Angptl3 silencing. This evidence concerns the gene ANGPTL4 and hyperlipidemia.